Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.
Saved in:
| Title: | Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes. |
|---|---|
| Authors: | Chen YH; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Medicine, School of Medicine, College of Medicine, National Defense Medical University, Taipei, Taiwan., Byers Kraus V; Department of Medicine, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA., Chang YS; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan., Lin TM; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan., Lee HY; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan., Chang CK; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan., Kuo TT; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei City, Taiwan., Chen JH; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei City, Taiwan.; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei City, Taiwan., Chang CC; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 252, Wu Hsing Street, Taipei City 110, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan. |
| Source: | Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2026 Mar 29; Vol. 18, pp. 1759720X261434279. Date of Electronic Publication: 2026 Mar 29 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101517322 Publication Model: eCollection Cited Medium: Print ISSN: 1759-720X (Print) Linking ISSN: 1759720X NLM ISO Abbreviation: Ther Adv Musculoskelet Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1759-720X |
|---|---|
| DOI: | 10.1177/1759720X261434279 |
